Skip to main content
. Author manuscript; available in PMC: 2011 Jul 1.
Published in final edited form as: Clin Neuropharmacol. 2010 Jul;33(4):191–197. doi: 10.1097/WNF.0b013e3181de8966

Figure 2.

Figure 2

A composite measure of low energy and fatigue (Panel A) from the BDI (mean +/- standard error the mean) increased more during IFN-α treatment in subjects with the A allele in the TNF-α upstream polymorphism; this trend was similar for a composite measure of crying, agitation, and irritability (Panel B) but was not significant.